Geoffrey Sklar, MD

Articles by Geoffrey Sklar, MD

The Possibility for Immunotherapy in Neoadjuvant Bladder Cancer Treatment

January 9th 2017

Geoffrey Sklar, MD, Chief Medical Officer, Chesapeake Urology Associates, discusses the possibility for immunotherapy as a neoadjuvant treatment in bladder cancer.

Latest Updated Articles

The Possibility for Immunotherapy in Neoadjuvant Bladder Cancer Treatment
Published: January 9th 2017 | Updated: